Page 192 - PRECONGRESS COURSE 06

Supplementation of luteal phase with rec LH in low risk for OHSS patients.
Severe OHSS
20
18
16
14
12
10
8 6 4 2 0
recLH
vag progesterone
0
0
n=18 n=17
Papanikolaou 2011
S
rG
S
u
up
p
p
p
l
l
e
e
m
m
e
e
n
n
t
t
a
at
t
i
io
on
no
o
f
fl
l
u
ut
te
ea
a
l
l
p
p
h
ha
a
s
s
e
ew
wi
it
t
h
h
r
re
e
c
c
L
LH
H
a
a
f
ft
t
e
e
r
G
n
n
R
R
H
H
a
ag
g
o
on
n
i
i
s
st
tt
t
r
r
i
i
g
gg
g
e
e
r
ri
i
n
ng
g
Conclusions
No severe OHSS cases were observed
when rec LH is given during the luteal phase after GnRH agonist triggering in low risk for OHSS patients.
192
Page 188 of 258
Severe OHSS incidence % 95% CI